Gene marks risk of VF (ventricular fibrillation) heart attacks:
This article was originally published in Clinica
Executive Summary
Heart attacks due to ventricular fibrillation are linked to genetic abnormalities in patients with no obvious cardiac disease, according to new US research. Mutations in the cardiac sodium channel gene SCN5A are responsible for the attacks - amounting to between 5% and 12% of VF cases. The gene could be used to assess individual risk through genetic testing, says the article (Nature March 19, p 293).
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.